Cancer-focused Alligator Bioscience is clamping down on costs, laying off 70% of its team in efforts to save around $6 million every year.
The workforce reduction is subject to negotiation with certain trade unions but will likely impact discovery and nonclinical roles. Alligator expects the restructure to slash annual operating costs by at least 65 million Swedish krona ($5.9 million), leaving 15 full-time employees on board.
https://www.fiercebiotech.com/biotech/alligator-bioscience-clamps-down-costs-cutting-70-workforce-stay-afloat